Friday, January 14, 2011

Sanofi May Lift Cash Portion of Genzyme Bid to as Much as $71, Figaro Says - Bloomberg

Sanofi-Aventis SA has accepted that it will have to increase the cash component of is bid for Genzyme Corp., and may raise the cash offer to $70 or $71 a share from $69, French daily Le Figaro reported, without citing anyone.

Sanofi is hoping to reach an agreement at an overall price of around $76 a share, including guaranteed value certificates which depend on future performance, the newspaper said.

To contact the editor responsible for this story: David Whitehouse at

Posted via email from Jack's posterous

No comments: